Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Regulation

DME Suppliers Await CBO Score On Competitive Bidding Alternative

This article was originally published in The Gray Sheet

  • News

Executive Summary

Durable medical equipment supplier groups pressed their “Market Pricing Program” during a May 9 House subcommittee hearing as an alternative to the Medicare competitive bidding program. The Congressional Budget Office is currently analyzing the proposal.

You may also be interested in...



Medicare Durable Equipment Cuts Will Deepen In Next Round Of Competitive Bidding

Starting July 1, Medicare plans to pay 45 percent less than current fee-schedule rates for eight categories of DMEPOS in 91 cities, and 72 percent less nationwide for diabetes products.

News In Brief

Given Imaging swallows SmartPill Corp. in $6 million acquisition deal. AdvaMed opens jobs program for veterans. Medical devices in space get funding. More news briefs.

News In Brief

More DME competitive bidding planned. AdvaMed outlines strategic plan. Roche ends Illumina bid, for now.

Table

View full table

Related Content

Medtech Insight
Medtech Insight

Topics

Tags:
Medical Device Regulation
Latest Headlines

Minute Insight: Enovis Buys Lima To Great Billion-Dollar Recon Business

Contingency Planning: Guidance Doc Details Handling Clinical Trials During Emergencies

ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study

Theradaptive Receives $7.4M From DoD, Advances Human Trials With ‘Paint-Like’ Regenerative Therapeutic

See All
UsernamePublicRestriction

Register

MT031212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By